angiotensin ii has been researched along with Blood Poisoning in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (10.20) | 18.7374 |
1990's | 5 (10.20) | 18.2507 |
2000's | 9 (18.37) | 29.6817 |
2010's | 13 (26.53) | 24.3611 |
2020's | 17 (34.69) | 2.80 |
Authors | Studies |
---|---|
Bonderski, V; Krishnan, K; Rech, MA; Tednes, P; Wassermann, TB | 1 |
Aydogan, MS; Baykan, S; Bicakcioglu, M; Bulut, N; Demircan, S; Dogan, Z; Duzenci, D; Ersoy, Y; Kalkan, S; Kibrislioglu Uysal, N; Korkmaz Disli, Z; Ozer, AB; Yucel, A; Yucel, N | 1 |
An, J; Hoshizaki, M; Imai, Y; Kuba, K; Minato, T; Nirasawa, S; Penninger, JM; Takahashi, S; Yamaguchi, T | 1 |
Abraham, MN; Bellomo, R; Brewer, MR; Capone, CC; Crowley, SD; Deutschman, CS; Fernandes, TD; Goldberg, MB; Griffiths, R; Lehman, JR; Leisman, DE; Nedeljkovic-Kurepa, A; Privratsky, JR; Stein, WJ; Taylor, MD; Yaipan, OY | 1 |
Alborino, E; Atalay, S; Bellomo, R; Çakmak, G; Carà, GA; de Paula, MS; Donmez, MB; Fonseca, M; Landoni, G; Pasin, L; Schimmel, M; Yilmaz, B; Zarbock, A | 1 |
Chai, YF; Chen, XS; Gao, YL; Liu, CY; Liu, YC; Meng, XL; Shou, ST; Wang, SH; Wei, W | 1 |
Baykan, S; Bicakcioglu, M; Bulut, N; Ersoy, Y; Kibrislioglu Uysal, N; Ozer, AB; Yucel, N | 1 |
Chai, YF; Chen, XS; Cui, JR; Gao, YL; Liu, YC; Meng, XL; Shou, ST; Wang, SH; Wei, W | 1 |
Choudhury, S; Garg, SK; Gari, M; Jagadeesh, T; Shukla, A; Singh, V | 1 |
Chlebowski, MM; Goldstein, SL; Kim, ME | 1 |
Bellomo, R; Garcia, B; Legrand, M; Zarbock, A | 1 |
Du, CB; Du, R; Li, DL; Liu, Y; Lu, P; Yang, XF; Zhang, YX; Zhao, ZT | 1 |
Evans, H; Ho, VP; Kaafarani, H; Namias, N; Rattan, R; Zakrison, TL | 1 |
Abraham, MN; Bellomo, R; Bijol, V; Capone, C; Deutschman, CS; Fernandes, TD; Lehman, JR; Leisman, DE; Taylor, MD; Yaipan, O | 1 |
Benzoni, N; Ellender, T | 1 |
Jiang, L; Liu, YJ; Mao, YF; Wang, Y; Xu, CF; Xu, DF; Zhu, XY | 1 |
Chen, S; Daugherty, A; Lin, Y; Lu, HS; Mullick, AE; Ning, L; Rong, J; Shi, P; Tao, X; Wang, J; Xu, Y; Zhang, Z; Zheng, H | 1 |
Bellomo, R; Evans, RG; Kosaka, J; Lankadeva, YR; May, CN | 1 |
Nunnally, ME; Patel, A | 1 |
Bailey, M; Bellomo, R; Burrell, LM; Calzavacca, P; May, CN; Ramchandra, R; Velkoska, E | 1 |
Akpinar, E; Bayir, Y; Cadirci, E; Calik, M; Halici, Z; Karakus, E; Polat, B; Topcu, A | 1 |
Bellomo, R; Booth, LC; Evans, RG; Kosaka, J; Lankadeva, YR; May, CN; Quintin, L | 1 |
Dünser, MW; Gradwohl-Matis, I | 1 |
Geloën, A; Quintin, L | 1 |
Assreuy, J; da Silva, LM; da Silva-Santos, JE; de Souza, P; Guarido, KL; Scheschowitsch, K; Werner, MF | 1 |
Hsu, JC; Lau, YT; Ma, YH; Yen, CH; Yu, HP | 1 |
Bellomo, R; Langenberg, C; May, CN; Wan, L | 1 |
Rocco, JR; Salgado, DR; Silva, E; Vincent, JL | 1 |
Chen, S; Ma, XC | 1 |
Bellomo, R; Ishikawa, K; Jackson, GD; May, CN; Pell, GS; Wan, L; Wellard, RM; Williams, J | 1 |
Frithiof, R | 1 |
Guardiola, JJ; Sarmiento, X; Soler, M | 1 |
Fischer, LG; Freise, H; Hilpert, JH; Lauer, S; Sielenkämper, AW; Van Aken, H; Wendholt, D | 1 |
Tyml, K; Wilson, JX; Wu, F | 1 |
Heresi, GA | 1 |
Duckworth, AJ; Goodship, AE; Kendall, HJ; Osborn, EC | 1 |
Crackower, MA; Fukamizu, A; Guan, B; Guo, F; Hein, L; Huan, Y; Hui, CC; Imai, Y; Jiang, C; Kuba, K; Leong-Poi, H; Penninger, JM; Rao, S; Sarao, R; Slutsky, AS; Uhlig, S; Wada, T; Yang, P | 1 |
Cameron, EM; Fink, MP; Sellke, FW; Wang, SY | 1 |
Boldt, J; Hempelmann, G; Kumle, B; Papsdorf, M; Piper, S | 1 |
Lew, WY; Yasuda, S | 1 |
Aneman, A; Bengtsson, J; Fändriks, L; Holm, M; Pettersson, A; Snygg, J | 1 |
Herndon, DN; Tadros, T; Traber, DL | 1 |
Bucher, M; Hobbhahn, J; Ittner, KP; Kurtz, A; Taeger, K | 1 |
Nielsen, MS; Thomas, VL | 1 |
Hilgenfeldt, U; Kellermann, W; Kienapfel, G; Schmidt, M; Schott, R | 1 |
Dziuban, SW; Goldfarb, RD; Lee, K; Luhmann, K; van der Zee, H | 1 |
Fink, MP; Fletcher, JR; Homer, LD | 1 |
Enderlin, F; Gigon, JP; Wolff, G | 1 |
Emmanouel, DS; Katz, AI | 1 |
9 review(s) available for angiotensin ii and Blood Poisoning
Article | Year |
---|---|
Beyond the bundle: Clinical controversies in the management of sepsis in emergency medicine patients.
Topics: Angiotensin II; Ascorbic Acid; Crystalloid Solutions; Disease Management; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Hydrocortisone; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic; Simendan; Thiamine | 2022 |
Topics: Angiotensin II; COVID-19; Humans; Renin-Angiotensin System; SARS-CoV-2; Sepsis; Vasoconstrictor Agents | 2022 |
The role of renin-angiotensin system in sepsis-associated acute kidney injury: mechanisms and therapeutic implications.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Humans; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Sepsis | 2023 |
Sepsis 2019: What Surgeons Need to Know.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Angiotensin II; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Carbapenem-Resistant Enterobacteriaceae; Drug Resistance, Multiple, Bacterial; Duration of Therapy; Enterobacteriaceae Infections; Enterococcus faecium; Enzyme Inhibitors; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Methicillin-Resistant Staphylococcus aureus; Methylene Blue; Organ Dysfunction Scores; Patient Care Bundles; Postoperative Complications; Practice Guidelines as Topic; Procalcitonin; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Shock, Septic; Staphylococcal Infections; Thiamine; Vancomycin-Resistant Enterococci; Vasoconstrictor Agents; Vitamin B Complex | 2020 |
Updates in Sepsis Resuscitation.
Topics: Angiotensin II; Anti-Bacterial Agents; Antioxidants; Ascorbic Acid; Blood Glucose; Blood Pressure; Cardiomyopathies; Cardiotonic Agents; Critical Illness; Emergency Service, Hospital; Enteral Nutrition; Fluid Therapy; Glucocorticoids; Hemodynamics; Humans; Organ Dysfunction Scores; Randomized Controlled Trials as Topic; Respiration, Artificial; Resuscitation; Sepsis; Vasoconstrictor Agents | 2020 |
Sepsis - What's new in 2019?
Topics: Angiotensin II; Anti-Bacterial Agents; Ascorbic Acid; Biomarkers; Combined Modality Therapy; Critical Care; Fluid Therapy; Glucocorticoids; Humans; Practice Guidelines as Topic; Procalcitonin; Resuscitation; Sepsis; Thiamine; Treatment Outcome | 2019 |
Modulation of the renin-angiotensin-aldosterone system in sepsis: a new therapeutic approach?
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Hemodynamics; Humans; Microcirculation; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sepsis | 2010 |
[Alcohol and acute respiratory distress syndrome: casuality or causality?].
Topics: Adaptive Immunity; Alcohol-Related Disorders; Alcoholism; Angiotensin II; Animals; Blood-Air Barrier; Causality; Cilia; Comorbidity; Cytokines; Disease Models, Animal; Disease Susceptibility; Humans; Inflammation Mediators; Liver Diseases, Alcoholic; Lung; Oxidative Stress; Phagocytosis; Pneumonia, Bacterial; Pulmonary Surfactants; Respiratory Distress Syndrome; Risk; Sepsis; Water-Electrolyte Imbalance; Wounds and Injuries; Zinc | 2013 |
Acute renal failure in obstetric septic shock. Current views on pathogenesis and management.
Topics: Abortion, Septic; Acute Kidney Injury; Analgesics; Angiotensin II; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Catecholamines; Digoxin; Disseminated Intravascular Coagulation; Diuretics; Dogs; Female; Hemodynamics; Humans; Hypnotics and Sedatives; Hypotension; Kidney; Kidney Concentrating Ability; Kidney Cortex Necrosis; Pregnancy; Pregnancy Complications, Infectious; Prostaglandins; Rabbits; Renal Dialysis; Renin; Sepsis; Shock, Septic; Sympathetic Nervous System; Tranquilizing Agents; Water-Electrolyte Balance | 1973 |
1 trial(s) available for angiotensin ii and Blood Poisoning
Article | Year |
---|---|
Influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cell Adhesion Molecules; Critical Illness; Double-Blind Method; Enalaprilat; Endothelin-1; Endothelium, Vascular; Female; Hemodynamics; Humans; Inflammation; Male; Middle Aged; Prospective Studies; Sepsis; Survival Analysis; Thrombomodulin | 1998 |
39 other study(ies) available for angiotensin ii and Blood Poisoning
Article | Year |
---|---|
Angiotensin II and angiotensin II receptor 2 levels can predict shock and mortality in septic patients.
Topics: Angiotensin II; Humans; Prognosis; Receptors, Angiotensin; Sepsis; Shock, Septic | 2022 |
ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury.
Topics: Acute Lung Injury; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Carboxypeptidases; COVID-19; Escherichia coli; Humans; Lung; Mice; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Respiratory Distress Syndrome; SARS-CoV-2; Sepsis | 2022 |
Angiotensin II enhances bacterial clearance via myeloid signaling in a murine sepsis model.
Topics: Angiotensin II; Animals; Bacteremia; Disease Models, Animal; Mice; Mice, Inbred C57BL; Myeloid Cells; Norepinephrine; Receptor, Angiotensin, Type 1; Sepsis; Signal Transduction | 2022 |
Losartan attenuates sepsis-induced cardiomyopathy by regulating macrophage polarization via TLR4-mediated NF-κB and MAPK signaling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomyopathies; Losartan; Macrophages; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Receptor, Angiotensin, Type 1; Sepsis; Toll-Like Receptor 4 | 2022 |
Hydrocortisone may act through the angiotensin II receptor-2 level in patients with catecholamine-resistant septic shock.
Topics: Angiotensin II; Catecholamines; Humans; Hydrocortisone; Sepsis; Shock, Septic | 2023 |
Angiotensin-(1-7) ameliorates sepsis-induced cardiomyopathy by alleviating inflammatory response and mitochondrial damage through the NF-κB and MAPK pathways.
Topics: Angiotensin II; Cardiomyopathies; Cells, Cultured; Humans; Mitogen-Activated Protein Kinases; NF-kappa B; Sepsis | 2023 |
Sepsis modulates aortic AT1 and P
Topics: Angiotensin II; Animals; Mice; RNA, Messenger; Sepsis; Uridine Diphosphate | 2023 |
Recombinant angiotensin II therapy in a child with cardiac dysfunction and
Topics: Angiotensin II; Candida; Child; Heart Diseases; Hemodynamics; Humans; Sepsis | 2023 |
Correlation between angiotensin and acute kidney injury in patients with sepsis.
Topics: Acute Kidney Injury; Angiotensin II; Humans; Intensive Care Units; Peptide Hormones; Prospective Studies; Retrospective Studies; Sepsis | 2023 |
Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Case-Control Studies; Humans; Losartan; Mice; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sepsis | 2021 |
Elevated angiotensin II induces platelet apoptosis through promoting oxidative stress in an AT1R-dependent manner during sepsis.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Blood Platelets; Case-Control Studies; Cell Proliferation; Cells, Cultured; Female; Gene Expression Regulation; Humans; Male; Mice; Middle Aged; Oxidative Stress; Prognosis; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Sepsis; Signal Transduction; Thrombocytopenia | 2021 |
Loss of Hepatic Angiotensinogen Attenuates Sepsis-Induced Myocardial Dysfunction.
Topics: Angiotensin II; Angiotensinogen; Animals; Heart Failure; Liver; Low Density Lipoprotein Receptor-Related Protein-1; Mice; Myocardium; NLR Family, Pyrin Domain-Containing 3 Protein; Sepsis | 2021 |
Urinary Oxygenation as a Surrogate Measure of Medullary Oxygenation During Angiotensin II Therapy in Septic Acute Kidney Injury.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Biomarkers; Blood Pressure; Cytokines; Disease Models, Animal; Female; Hemodynamics; Kidney Function Tests; Kidney Medulla; Oxygen; Sepsis; Sheep | 2018 |
Effects of renal denervation on regional hemodynamics and kidney function in experimental hyperdynamic sepsis.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Creatinine; Denervation; Disease Models, Animal; Escherichia coli Infections; Female; Glomerular Filtration Rate; Hemodynamics; Kidney; Norepinephrine; Renal Artery; Renal Circulation; Sepsis; Sheep; Sympathetic Nervous System | 2014 |
What is the role of renin inhibition during rat septic conditions: preventive effect of aliskiren on sepsis-induced lung injury.
Topics: Amides; Angiotensin II; Animals; Fumarates; Glutathione; Lipid Peroxidation; Lung Injury; Male; Oxidative Stress; Rats; Rats, Wistar; Renin; Sepsis; Treatment Outcome | 2014 |
Clonidine Restores Pressor Responsiveness to Phenylephrine and Angiotensin II in Ovine Sepsis.
Topics: Adrenergic alpha-2 Receptor Agonists; Angiotensin II; Animals; Blood Pressure; Clonidine; Female; Hypotension; Kidney; Phenylephrine; Sepsis; Sheep; Sympathetic Nervous System; Vasoconstrictor Agents | 2015 |
Reverse Physiology: Applying an Antihypertensive Drug to Increase Arterial Blood Pressure in Septic Shock.
Topics: Adrenergic alpha-2 Receptor Agonists; Angiotensin II; Animals; Blood Pressure; Clonidine; Female; Hypotension; Phenylephrine; Sepsis; Sympathetic Nervous System; Vasoconstrictor Agents | 2015 |
Reverse Physiology, i.e., Cellular Versus Integrative Versus Comparative Physiology? α-2 Agonists and Septic Shock.
Topics: Adrenergic alpha-2 Receptor Agonists; Angiotensin II; Animals; Blood Pressure; Clonidine; Female; Hypotension; Phenylephrine; Sepsis; Sympathetic Nervous System; Vasoconstrictor Agents | 2016 |
Impaired vascular function in sepsis-surviving rats mediated by oxidative stress and Rho-Kinase pathway.
Topics: Amides; Angiotensin II; Animals; Aorta, Thoracic; Endothelium, Vascular; Male; Oxidative Stress; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species; rho-Associated Kinases; Sepsis; Signal Transduction; Superoxide Dismutase | 2016 |
Hyporeactivity of renal artery to angiotensin II in septic rats.
Topics: Angiotensin II; Animals; Blood Pressure; Cecum; Ligation; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renal Artery; Renal Circulation; Sepsis; Vascular Resistance | 2008 |
Angiotensin II in experimental hyperdynamic sepsis.
Topics: Angiotensin II; Animals; Creatinine; Diuresis; Escherichia coli Infections; Female; Hemodynamics; Renal Circulation; Sepsis; Sheep; Shock, Septic | 2009 |
[Effect of heparin on the levels of interleukin-6, tumor necrosis factor-α and angiotensin II in rat with sepsis].
Topics: Angiotensin II; Animals; Heparin; Interleukin-6; Male; Rats; Rats, Wistar; Sepsis; Tumor Necrosis Factor-alpha | 2010 |
Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion.
Topics: Adenosine Triphosphate; Angiotensin II; Animals; Energy Metabolism; Escherichia coli; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Kidney; Sepsis; Sheep; Vasoconstrictor Agents | 2012 |
Sepsis-induced acute kidney injury—is there a lack of energy?
Topics: Angiotensin II; Animals; Energy Metabolism; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Kidney; Sepsis; Vasoconstrictor Agents | 2012 |
Modulation of hypoxic pulmonary vasoconstriction is time and nitric oxide dependent in a peritonitis model of sepsis.
Topics: Angiotensin II; Animals; Blood Pressure; Blotting, Western; Enzyme Inhibitors; Hypoxia; In Vitro Techniques; Lung; Lysine; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peritonitis; Prospective Studies; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Sepsis; Time Factors; Vasoconstriction | 2004 |
Ascorbate protects against impaired arteriolar constriction in sepsis by inhibiting inducible nitric oxide synthase expression.
Topics: Angiotensin II; Animals; Arterioles; Ascorbic Acid; Blood Pressure; Cecum; Drug Administration Schedule; Enzyme Induction; Intestinal Perforation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Oxidative Stress; RNA, Messenger; Sepsis; Vasoconstriction | 2004 |
Acute renal failure and sepsis.
Topics: Acute Kidney Injury; Angiotensin II; Arginine Vasopressin; Humans; Sepsis; Vasoconstrictor Agents | 2004 |
Pressor and intra-renal effects of angiotensins I and II, and noradrenaline, in anaesthetized and conscious sheep. The effects of halothane anaesthesia on pressor sensitivity and electrolyte shifts: the proposed use of angiotensin I in treating septicaemi
Topics: Angiotensin I; Angiotensin II; Animals; Electrolytes; Halothane; Kidney; Norepinephrine; Sepsis; Sheep; Shock, Septic | 2005 |
Angiotensin-converting enzyme 2 protects from severe acute lung failure.
Topics: Acids; Acute Disease; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Capillary Permeability; Carboxypeptidases; Disease Models, Animal; Gene Deletion; Humans; Lung; Lung Diseases; Mice; Mice, Knockout; Mice, Transgenic; Oxygen; Peptidyl-Dipeptidase A; Pulmonary Edema; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Respiratory Distress Syndrome; Sepsis; Transgenes | 2005 |
Mesenteric and skeletal muscle microvascular responsiveness in subacute sepsis.
Topics: Angiotensin II; Animals; Blood Vessels; Disease Models, Animal; Hemodynamics; Male; Microcirculation; Microscopy, Video; Muscle, Skeletal; Peritonitis; Phenylephrine; Prazosin; Rats; Rats, Sprague-Dawley; Sepsis; Splanchnic Circulation; Staurosporine; Vascular Resistance | 1998 |
Angiotensin II exacerbates lipopolysaccharide-induced contractile depression in rabbit cardiac myocytes.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Calcium; Cells, Cultured; Chelating Agents; Cyclic GMP; Enzyme Inhibitors; Female; Heart Ventricles; Imidazoles; Indoles; Lipopolysaccharides; Losartan; Male; Mitochondria; Muscle Fibers, Skeletal; Myocardial Contraction; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rabbits; Receptors, Angiotensin; Sepsis; Ventricular Function | 1999 |
Differentiation of the peptidergic vasoregulatory response to standardized splanchnic hypoperfusion by acute hypovolaemia or sepsis in anaesthetized pigs.
Topics: Acute Disease; Anesthesia; Angiotensin II; Animals; Atrial Natriuretic Factor; Endothelin-1; Escherichia coli Infections; Female; Femoral Vein; Hemorrhage; Hypovolemia; Male; Neuropeptides; Portal Vein; Sepsis; Splanchnic Circulation; Swine; Vasoconstrictor Agents | 1999 |
Trauma- and sepsis-induced hepatic ischemia and reperfusion injury: role of angiotensin II.
Topics: Analysis of Variance; Angiotensin II; Animals; Burns; Drug Evaluation, Preclinical; Escherichia coli; Female; Hemodynamics; Ischemia; Lipopolysaccharides; Liver; Losartan; Random Allocation; Reperfusion Injury; Sepsis; Swine; Swine, Miniature; Wounds and Injuries | 2000 |
Downregulation of angiotensin II type 1 receptors during sepsis.
Topics: Adrenal Glands; Angiotensin II; Animals; Blood Pressure; Cells, Cultured; Cytokines; Down-Regulation; Drug Antagonism; Glomerular Mesangium; Lipopolysaccharides; Liver; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Sepsis; Teichoic Acids; Tissue Distribution | 2001 |
Administration of angiotensin II in refractory septic shock.
Topics: Adult; Angiotensin II; Combined Modality Therapy; Critical Care; Drug Therapy, Combination; Female; Hemodynamics; Humans; Pneumococcal Infections; Sepsis; Shock, Septic | 1991 |
Renin-angiotensin system in sepsis.
Topics: Acute Kidney Injury; Angiotensin I; Angiotensin II; Epinephrine; Furosemide; Humans; Multiple Trauma; Peptidyl-Dipeptidase A; Pneumonia; Renin; Renin-Angiotensin System; Respiratory Distress Syndrome; Sepsis | 1987 |
Left ventricular function during chronic endotoxemia in swine.
Topics: Analysis of Variance; Angiotensin II; Animals; Cardiac Output; Endotoxins; Heart; Hemodynamics; Salmonella Infections, Animal; Sepsis; Swine | 1988 |
Diminished pressor response to exogenous norepinephrine and angiotensin II in septic, unanesthetized rats: evidence for a prostaglandin-mediated effect.
Topics: Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Dose-Response Relationship, Drug; Electrolytes; Epoprostenol; Hydrogen-Ion Concentration; Indomethacin; Male; Norepinephrine; Oxygen; Prostaglandins E; Rats; Rats, Inbred Strains; Sepsis | 1985 |
[Shock therapy with vasodilator and-or vasoconstrictor agents].
Topics: Adult; Aged; Angiotensin II; Blood Pressure; Diuresis; Female; Humans; Isoproterenol; Norepinephrine; Sepsis; Shock; Vascular Diseases; Vasoconstrictor Agents; Vasodilator Agents | 1967 |